Anteris Technologies Global Corp. (AVR) Form 10-Q Quarterly Reports
Anteris Technologies Global Corp. (AVR) is a publicly traded company on the Nasdaq, categorized under SIC 3842 (Orthopedic, Prosthetic & Surgical Appliances & Supplies). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: AVR
CIK: 2011514
Exchange: Nasdaq
SIC 3842: Orthopedic, Prosthetic & Surgical Appliances & Supplies
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG
Auditor SinceSince 9/30/2024 12:00:00 AM
Lead Engagement PartnerStephen Board
Audit LocationBrisbane, Australia
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-08 | 2026-10-06 | PRIMARY DOCUMENT | 0001817646-26-000032 | View SEC Doc Filr Page |
| 4 | 2026-10-06 | 2026-10-02 | PRIMARY DOCUMENT | 0001817646-26-000029 | View SEC Doc Filr Page |
| 4 | 2026-10-01 | 2026-09-30 | PRIMARY DOCUMENT | 0001817646-26-000028 | View SEC Doc Filr Page |
| 424B3 | 2026-09-24 | — | 424B3 | 0001140361-26-037576 | View SEC Doc Filr Page |
| 8-K | 2026-09-23 | 2026-09-23 | 8-K | 0001140361-26-037392 | View SEC Doc Filr Page |
| 424B3 | 2026-09-21 | — | 424B3 | 0001140361-26-037194 | View SEC Doc Filr Page |
| 8-K | 2026-09-17 | 2026-09-12 | 8-K | 0001140361-26-037002 | View SEC Doc Filr Page |
| 4 | 2026-09-16 | 2026-09-11 | FORM 4 | 0001140361-26-036763 | View SEC Doc Filr Page |
| 3 | 2026-09-16 | 2026-09-11 | FORM 3 | 0001140361-26-036762 | View SEC Doc Filr Page |
| 424B3 | 2026-09-09 | — | 424B3 | 0001140361-26-036057 | View SEC Doc Filr Page |
| 8-K | 2026-09-08 | 2026-09-04 | 8-K | 0001140361-26-035840 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-09-03 | — | SCHEDULE 13G/A Filing | 0001817646-26-000027 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-08-28 | PRIMARY DOCUMENT | 0001817646-26-000026 | View SEC Doc Filr Page |
| 4 | 2026-08-20 | 2026-08-19 | FORM 4 | 0001140361-26-033942 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001104659-26-097295 | View SEC Doc Filr Page |
| 424B3 | 2026-08-12 | — | 424B3 | 0001140361-26-032391 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-10 | PRIMARY DOCUMENT | 0001817646-26-000020 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-11 | 8-K | 0001140361-26-032296 | View SEC Doc Filr Page |
| 10-Q | 2026-08-11 | 2026-06-30 | 10-Q | 0001140361-26-032232 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-06 | PRIMARY DOCUMENT | 0001817646-26-000019 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-07 | — | SCHEDULE 13G/A Filing | 0001817646-26-000018 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-06 | — | SCHEDULE 13G Filing | 0000315066-26-001936 | View SEC Doc Filr Page |
| 4 | 2026-08-06 | 2026-08-04 | PRIMARY DOCUMENT | 0001817646-26-000017 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-07-31 | PRIMARY DOCUMENT | 0001817646-26-000016 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-08-03 | 8-K | 0001140361-26-030586 | View SEC Doc Filr Page |